Welcome to the International 
Immunocompromised Host Society


Ballots for the 2021 elections have been counted.  We are pleased to announce the winners of the 2021 ICHS Council election.  Thanks to all members who voted, and special thanks to the Council members who work for the success of this Society.


Dr Dimitrios P Kontoyiannis, past ICHS president, is pleased to share the Core Recommendations for Antifungal Stewardship (to be published as supplement in JID Sept 1, 2020) he spearheaded on behalf of the Mycoses Study Group Education and Research Consortium (MSGERC).

The 21st ICHS Symposium has concluded.

Thank you again for attending last week's 21st ICHS Symposium on Infections in the Immunocompromised Host. We hope you had an enjoyable experience and have come away with new knowledge and network opportunities.

Please review the winners of the Lifetime Achievement Award and the Young investigator Awards, as well as awards for best abstracts and posters.  These presentations were made during the closing ceremony.

A reminder that presentation recordings will be available to all registered attendees via the virtual portal, using the same login details for the next three months.

Upcoming events

28 May 2021 • Athens, Greece

Looking for new opportunities? 

ICHS is helping to support our community by advertising employment opportunities. 

Visit our new page

Hear from our Council!

Several members of our International  Council have recorded messages about the ICHS Society and the 2021 Symposium.  Click here to hear what they have to say!

Please visit the MSGERC Mycoses Study Group Education & Research Consortium website MSGERC.ORG to keep up with the latest news!

Be sure to visit the NEW Doctor Fungus Website at msgercdoctorfungus.com/   You'll find a wealth of valuable information!

European Conference on Infections in Leukaemia (ECIL) news

We are pleased to inform you that the final slide sets of the ECIL 7 working groups CMV, HHV6 and vaccines are now available on the ECIL website at www.ecil-leukaemia.com. You will find these sets in the Program section.

ECIL Guidelines

Don't forget to review the new ECIL Guidelines

 An update from the ICHS   meeting in Athens

The field of clinical and translational research in febrile neutropenia started in the early1960s with the classic autopsy studies at NCI in patients with leukemia, followed by the seminal work by Gerald Bodey about the quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Other giants of that era built on these observations and defined the practice of antibiotic and antifungal management in these patients. ICHS had pivotal contributions in organizing guidelines for the design, analysis, reporting of clinical trials on the antibiotic management in that vulnerable patient population (JID 1990; 161: 397-401) . It was befitting that Philip Pizzo one of the trailblazers of that era and an early founder of ICHS was the inaugural speaker of the Athens ICHS 2018 meeting,  a meeting that  reflected on the 40 year history of ICHS and over half of century studies in the field of clinical research infections in neutropenic cancer patients. His thoughtful talk, was the ímpetus for a comprehensive piece that was recently published in the Annals of Internal Medicine (Management of Patients With Fever and Neutropenia Through the Arc of Time: A Narrative Review.)
Pizzo PA.Ann Intern Med. 2019 Mar 12. doi: 10.7326/M18-3192. [Epub ahead of print], PMID:30856657--Download here

Dimitrios P Kontoyiannis, MD, ScD, PhD (Hon)
ICHS President 2016-2018

© International Immunocompromised Host Society
Powered by Wild Apricot Membership Software